Nichols launches chemiluminescence system:
This article was originally published in Clinica
Executive Summary
Nichols Institute has launched an automated benchtop assay system based on direct-label chemiluminescence. The Nichols Advantage system uses magnetic particle separation. It can accommodate 15 on-board tests and features a data management and local area network system. The analyser has not yet been cleared by the FDA and will be unveiled at Medica in Germany with a menu including reproductive and thyroid hormones, and cancer markers.